236 related articles for article (PubMed ID: 30928199)
1. Clinical and genetic spectrum of SCN2A-associated episodic ataxia.
Schwarz N; Bast T; Gaily E; Golla G; Gorman KM; Griffiths LR; Hahn A; Hukin J; King M; Korff C; Miranda MJ; Møller RS; Neubauer B; Smith RA; Smol T; Striano P; Stroud B; Vaccarezza M; Kluger G; Lerche H; Fazeli W
Eur J Paediatr Neurol; 2019 May; 23(3):438-447. PubMed ID: 30928199
[TBL] [Abstract][Full Text] [Related]
2. Episodic ataxia associated with a de novo SCN2A mutation.
Leach EL; van Karnebeek CD; Townsend KN; Tarailo-Graovac M; Hukin J; Gibson WT
Eur J Paediatr Neurol; 2016 Sep; 20(5):772-6. PubMed ID: 27328862
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.
Schwarz N; Hahn A; Bast T; Müller S; Löffler H; Maljevic S; Gaily E; Prehl I; Biskup S; Joensuu T; Lehesjoki AE; Neubauer BA; Lerche H; Hedrich UBS
J Neurol; 2016 Feb; 263(2):334-343. PubMed ID: 26645390
[TBL] [Abstract][Full Text] [Related]
4. The phenotypic spectrum of SCN2A-related epilepsy.
Reynolds C; King MD; Gorman KM
Eur J Paediatr Neurol; 2020 Jan; 24():117-122. PubMed ID: 31924505
[TBL] [Abstract][Full Text] [Related]
5. Dominant SCN2A mutation with variable phenotype in two generations.
Passi GR; Mohammad SS
Brain Dev; 2021 Jan; 43(1):166-169. PubMed ID: 32893078
[TBL] [Abstract][Full Text] [Related]
6. Dominant SCN2A Mutation Causes Familial Episodic Ataxia and Impairment of Speech Development.
Fazeli W; Becker K; Herkenrath P; Düchting C; Körber F; Landgraf P; Nürnberg P; Altmüller J; Thiele H; Koy A; Liebau MC; Simon T; Dötsch J; Cirak S
Neuropediatrics; 2018 Dec; 49(6):379-384. PubMed ID: 30165711
[TBL] [Abstract][Full Text] [Related]
7. Whole-Exome Sequencing Implicates
Maksemous N; Smith RA; Sutherland HG; Sampaio H; Griffiths LR
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314295
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and genetic spectrum of SCN2A gene associated epilepsy and episodic ataxia].
Guan J; Du KX; Dong Y; Li L; Song PP; Gong H; Zhang XL; Jia TM
Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):51-55. PubMed ID: 34986624
[No Abstract] [Full Text] [Related]
9. A De Novo HECW2 Variant in a Patient with Acetazolamide-Responsive Episodic Ataxia.
Tedesco Silva LM; Sharma S; Schrauwen I; Margolesky J; Detyniecki K
Cerebellum; 2023 Oct; 22(5):1029-1033. PubMed ID: 35987951
[TBL] [Abstract][Full Text] [Related]
10. Further delineation of phenotypic spectrum of SCN2A-related disorder.
Richardson R; Baralle D; Bennett C; Briggs T; Bijlsma EK; Clayton-Smith J; Constantinou P; Foulds N; Jarvis J; Jewell R; Johnson DS; McEntagart M; Parker MJ; Radley JA; Robertson L; Ruivenkamp C; Rutten JW; Tellez J; Turnpenny PD; Wilson V; Wright M; Balasubramanian M
Am J Med Genet A; 2022 Mar; 188(3):867-877. PubMed ID: 34894057
[TBL] [Abstract][Full Text] [Related]
11. Understanding the schizophrenia phenotype in the first patient with the full SCN2A phenotypic spectrum.
Suddaby JS; Silver J; So J
Psychiatr Genet; 2019 Jun; 29(3):91-94. PubMed ID: 30741786
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond.
Wolff M; Brunklaus A; Zuberi SM
Epilepsia; 2019 Dec; 60 Suppl 3():S59-S67. PubMed ID: 31904126
[TBL] [Abstract][Full Text] [Related]
13. [Phenotype study of SCN2A gene related epilepsy].
Zeng Q; Zhang YH; Yang XL; Zhang J; Liu AJ; Liu XY; Jiang YW; Wu XR
Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):518-523. PubMed ID: 29996185
[No Abstract] [Full Text] [Related]
14.
Yang XR; Ginjupalli VKM; Theriault O; Poulin H; Appendino JP; Au PYB; Chahine M
J Neurophysiol; 2022 May; 127(5):1388-1397. PubMed ID: 35417276
[TBL] [Abstract][Full Text] [Related]
15. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain.
Liao Y; Anttonen AK; Liukkonen E; Gaily E; Maljevic S; Schubert S; Bellan-Koch A; Petrou S; Ahonen VE; Lerche H; Lehesjoki AE
Neurology; 2010 Oct; 75(16):1454-8. PubMed ID: 20956790
[TBL] [Abstract][Full Text] [Related]
16. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
[TBL] [Abstract][Full Text] [Related]
17. Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.
Corbett MA; Bellows ST; Li M; Carroll R; Micallef S; Carvill GL; Myers CT; Howell KB; Maljevic S; Lerche H; Gazina EV; Mefford HC; Bahlo M; Berkovic SF; Petrou S; Scheffer IE; Gecz J
Neurology; 2016 Nov; 87(19):1975-1984. PubMed ID: 27733563
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features.
Liang JS; Lin LJ; Yang MT; Wang JS; Lu JF
Brain Dev; 2017 Nov; 39(10):877-881. PubMed ID: 28709814
[TBL] [Abstract][Full Text] [Related]
19. Novel SCN2A mutation in a family associated with juvenile-onset myoclonus: Case report.
Huang Q; Yu L; Ma M; Qi H; Wu Y
Medicine (Baltimore); 2019 Feb; 98(8):e14698. PubMed ID: 30813219
[TBL] [Abstract][Full Text] [Related]
20. Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human iPSCs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.
Que Z; Olivero-Acosta MI; Zhang J; Eaton M; Tukker AM; Chen X; Wu J; Xie J; Xiao T; Wettschurack K; Yunis L; Shafer JM; Schaber JA; Rochet JC; Bowman AB; Yuan C; Huang Z; Hu CD; Trader DJ; Skarnes WC; Yang Y
J Neurosci; 2021 Dec; 41(49):10194-10208. PubMed ID: 34716231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
